These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 31884801

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. MicroRNA-425-5p regulates chemoresistance in colorectal cancer cells via regulation of Programmed Cell Death 10.
    Zhang Y, Hu X, Miao X, Zhu K, Cui S, Meng Q, Sun J, Wang T.
    J Cell Mol Med; 2016 Feb; 20(2):360-9. PubMed ID: 26647742
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL, Wang W, Lan XL, Zeng ZC, Liang YS, Yan YR, Song FY, Wang FF, Zhu XH, Liao WJ, Liao WT, Ding YQ, Liang L.
    Mol Cancer; 2019 May 07; 18(1):91. PubMed ID: 31064356
    [Abstract] [Full Text] [Related]

  • 27. Through oxaliplatin resistance induction in colorectal cancer cells, increasing ABCB1 level accompanies decreasing level of miR-302c-5p, miR-3664-5p and miR-129-5p.
    Ghanbarian M, Afgar A, Yadegarazari R, Najafi R, Teimoori-Toolabi L.
    Biomed Pharmacother; 2018 Dec 07; 108():1070-1080. PubMed ID: 30372807
    [Abstract] [Full Text] [Related]

  • 28. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B, Liu Y, Zhao L, Pan Y, Shan Y, Li Y, Jia L.
    Mol Carcinog; 2017 Dec 07; 56(12):2669-2680. PubMed ID: 28767179
    [Abstract] [Full Text] [Related]

  • 29. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
    Ginés A, Bystrup S, Ruiz de Porras V, Guardia C, Musulén E, Martínez-Cardús A, Manzano JL, Layos L, Abad A, Martínez-Balibrea E.
    PLoS One; 2015 Dec 07; 10(5):e0123830. PubMed ID: 25955657
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Li J, Li X, Cen C, Ai X, Lin C, Hu G.
    Oncol Rep; 2018 Jan 07; 39(1):217-226. PubMed ID: 29115526
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy via transforming growth factor-β/Smad4 pathway.
    Sun C, Wang FJ, Zhang HG, Xu XZ, Jia RC, Yao L, Qiao PF.
    World J Gastroenterol; 2017 Mar 14; 23(10):1816-1827. PubMed ID: 28348487
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1.
    Shan Y, Liu Y, Zhao L, Liu B, Li Y, Jia L.
    Int J Biochem Cell Biol; 2017 Sep 14; 90():48-58. PubMed ID: 28751193
    [Abstract] [Full Text] [Related]

  • 36. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T, Hou J, Liu C, Shan F, Xiong X, Qin A, Chen J, Ren W.
    Biomed Pharmacother; 2019 Sep 14; 117():109171. PubMed ID: 31261026
    [Abstract] [Full Text] [Related]

  • 37. Targeting hexokinase 2 increases the sensitivity of oxaliplatin by Twist1 in colorectal cancer.
    Zhang B, Chan SH, Liu XQ, Shi YY, Dong ZX, Shao XR, Zheng LY, Mai ZY, Fang TL, Deng LZ, Zhou DS, Chen SN, Li M, Zhang XD.
    J Cell Mol Med; 2021 Sep 14; 25(18):8836-8849. PubMed ID: 34378321
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines.
    Chai H, Liu M, Tian R, Li X, Tang H.
    Acta Biochim Biophys Sin (Shanghai); 2011 Mar 14; 43(3):217-25. PubMed ID: 21242194
    [Abstract] [Full Text] [Related]

  • 40. Astragaloside IV Induced miR-134 Expression Reduces EMT and Increases Chemotherapeutic Sensitivity by Suppressing CREB1 Signaling in Colorectal Cancer Cell Line SW-480.
    Ye Q, Su L, Chen D, Zheng W, Liu Y.
    Cell Physiol Biochem; 2017 Mar 14; 43(4):1617-1626. PubMed ID: 29041002
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.